Magnetic resonance imaging differentiation of adrenal masses at 1.5 T: T2-weighted images, chemical shift imaging, and Gd-DTPA dynamic studies

Magnetic Resonance Materials in Physics, Biology, and Medicine

Volumn 4, Issue 3-4, 1996, Pages 163-179

  Slapa R Z ^a   Jakubowski, W ^a   Dabrowska E ^a   Januszewicz, A ^a   Tyminska B ^a   Feltynowski, T ^a   LApinSki M ^a   Fijuth, J ^b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Chemical shift imaging; Differentiation of adrenal masses; Gd DTPA enhanced dynamic studies; Magnetic resonance imaging

Indexed keywords

ALDOSTERONE; GADOLINIUM PENTETATE;

ADRENAL CORTEX ADENOMA; ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ADENOMA; ADRENAL CORTEX NEOPLASMS; ALDOSTERONE; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; GADOLINIUM; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID; PHEOCHROMOCYTOMA;

EID: 0030423221     PISSN: 13528661     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01772004     Document Type: Article

References (34)

1. DeVita VT, Jr, Hellman S, Rosenberg SA (1993) Cancer: Principles and Practice of Oncology, pp. 1286-1303. J.B. Lippincott Company.
2. Gils APG, Erkel AR, Falke IHM, Pauwels EKJ (1994) Magnetic resonance imaging or metaiodobertzylguanidine scintigraphy for the demonstration of paragangliomas? Eur. J. Nucl. Med. 21: 239-253.
3. Korobkin M, Dunnick NR (1995) Characterization of adrenal masses. AJR 164: 643-644.
4. Korobkin M, Lombardi TJ, Aisen AM, et al. (1995) Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. Radiology 197: 411-418.
5. Maurea S, Cuocolo A, Reynolds JC, Sabah ST (1993) Iodine-131-metaiodobenzylguanidine scintigraphy in preoperative and postoperative evaluation of paragangliomas: comparison with CT and MRI. J Nucl Med 34: 173-179.
6. Neumann HPH, Berger DP, Sigmund S, Blum U (1993) Pheochromocytomas, multiple endocrine neoplasia type 2 and Von Hippel-Lindau disease. N Engl J Med 329: 1531-1538.
7. Reinig JW, Stutley JE, Leonhardt CM, et al. (1994) Differentiation of adrenal masses with MR imaging: comparison of techniques. Radiology 192: 41-46.
8. Reinig JW (1992) MR imaging differentiation of adrenal masses: has the time finally come? Radiology 185: 339-340.
9. Schwartz LH, Doyle MV, Panicek DM, et al. (1995) Clinical utility and cost effectiveness of adrenal mass evaluation with MRI in patients with malignancy. III SMR meeting Nice: 370.
10. Ichikawa T, Fujimoto H, Murakami K, et al. (1993) Adrenal tissue characterization with 0.5-T MR imaging: value of T2*-weighted images. JMRI 3: 742-745.
11. Ichikawa T, Ohtomo K, Uchiyama G, Koizumi K (1994) Adrenal adenomas: characteristic hyperintense rim sign on fat-saturated spin-echo MR images. Radiology 193: 247-250.
12. Mitchell DG, Crovello M, Matteucci T, et al. (1992) Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology 185: 345-351.
13. Outwater EK, Mitchell DG (1994) Differentiation of adrenal masses with chemical shift MR imaging. Radiology 192: 877-879.
14. Schlund JF, Kenney PJ, Brown ED, Ascher SM (1995) Adrenocortical carcinoma: MR imaging appearance with current techniques. JMRI 5: 171-174.
15. Schwartz LH, Panicek DM, Koutcher JA, et al. (1995) Adrenal masses in patients with malignancy: prospective comparison of echo-planar, fast spin-echo, and chemical shift MR imaging. Radiology 197: 421-425.
16. Tsushima Y, Ishizaka H, Matsumotot M (1993) Adrenal masses: differentiation with chemical shift, fast low-angle shot MR imaging. Radiology 186: 705-709.
17. Pacho R, Andrzejewska M, Feltynowski T, et al (1993) Estimation of aldosteroma growth by computed tomography. ECR meeting Vienna: 297.
18. Ichikawa T, Ohtomo K, Uchiyama G, et al (1994) Adrenal adenomas: characteristic hyperintense rim sign on fatsaturated spin-echo MR images. Radiology 193: 247-250.
19. Mirowitz SA, Gutierrez E, Lee JKT et al. (1991) Normal abdominal enhancement patterns with dynamic gadolinium-enhanced MR imaging. Radiology 18: 637-640.
20. Krestin GP, Friedmann G, Fischbach R, Neufang FR (1991) Evaluation of adrenal masses in oncologic patients: dynamic contrast-enhanced MR vs. CT. J Comput Assist Tomogr 15: 104-110.
21. Chiesura-Corona M, Feltrin GP, Rossi GP, Miotto D (1993) MR versus CT in the diagnosis of aldosterone producing adenoma. ECR meeting Vienna: 298.
22. Rossi GP, Chiesura-Corona M, Tregnaghi A, et al. (1993) Imaging of aldosterone-secreting adenomas: a prospective comparison of computed tomography and magnetic resonance imaging in 27 patients with suspected primary aldosteronism. J Hum Hypertens 7: 357-363.
23. Kreft B, Sommer T, Vahlensieck M, Seewald S (1994) Turbo-spin-echo (TSE) sequences with spectrally selective fat saturation (SPIR) vs. chemical shift imaging in the differentiation of adrenal masses. II SMR meeting San Francisco: 1533.
24. Słapa RZ, Jakubowski W, Dabrowska E, et al. (1996) MR differentiation of adrenal masses at 1.5T: SE T2 weighted images and chemical shift imaging. IV ISMRM meeting New York: 223.
25. Gross MD, Shapiro B (1993) Clinical review: 50 clinically silent masses. J Clin Endocrinol Metab 77: 885-888.
26. Welch TJ, Sheedy PF, Stephens DH, et al. (1994) Percutaneous adrenal biopsy: review of a 10-year experience. Radiology 193: 341-344.
27. Leroy-Willing A, Roucayrol JC, Luton JP, Courtieu J (1987) In vitro adrenal cortex lesion characterization by NMR spectroscopy. Magn Reson Imaging 5: 339-344.
28. Leroy-Willing A, Bittoun J, Luton JP, Louvel A (1989) In vivo MR spectroscopic imaging of the adrenal glands: distinction between adenomas and carcinomas larger than 15 mm based on lipid content. ARJ 153: 771-773.
29. Hertzler G, Walthr MM, Gilarsky BP, et al (1989) The adrenal gland. In Someren A, ed. Urologie pathology with clinical and radiologie correlations, pp. 660-742. MacMillan.
30. Reinig JW (1992) MR imaging differentiation of adrenal masses: has the time finally come? Radiology 185: 339-340.
31. Vaupel P, Kallinowski F, Okunieff P (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49: 6449-6465.
32. Verstraete KL, Deene Y, Roels H, et al. (1994) Benign and malignant musculoskeletal lesions: dynamic contrast-enhanced MR imaging-parametric "first-pass" images depict tissue vascularization and perfusion. Radiology 192: 835-843.
33. Semelka RC, Shoenut JP, Lawrence PH, et al. (1993) Evaluation of adrenal masses with gadolinium enhancement and fat-suppressed MR imaging. JMRI 3: 337-343.
34. Kaplan NM (1994) Clinical hypertension, pp. 367-419. Baltimore: William & Wilkins.